R&D Center
Located in Shandong Jinan Pharmacetical Valley Park, our R&D center now has more than 30 R&D staffs, including 5 PhD&11 masters, all of them have rich R&D experience; moreover, we found a 1,000 square meters of laboratory in Jinan city of Shandong province, with synthetic laboratory, analytical laboratoriy, Salt formation and crystal form laboratory, etc.; There are complete supporting equipment in laboratory, including high-performance liquid chromatography, liquid chromatograph/mass spectrometer, high and low temperature one machine, 50L and 100L reactor, 100L hydrogenation reactor and other equipment.
It is mainly responsible for the connection of synthesis process of raw materials and intermediates, connection of customized products, as well as the transformation&engagement of laboratory technology to pilot process.
Products list
- Afatinib (BIBW2992)API and i
- Nitedanib(BIBF-1120) API and
- Tedizolid API and intermedia
- Lenvatinib API and intermedi
- Vonoprazan(TAK-438) API and
- Osimertinib(AZD9291) interme
- Olaparib API and intermedia
- Apixaban intermediates
- Carbozantinib intermediates
- Neratinib(HKI-272) API and i
- Ceritinib(LDK378) API and in
- Dacomitinib intermediates
- Trifluridine (TAS-102) API a
- Rucaparib API and intermedia
- Lesinuard(RDEA594) API and i
- Eltrombopag intermediates
- Rilpivirine intermediates
- Avatrombopag intermediates
- Relugolix intermediates
- Bedaquiline intermediates
- Eluxadoline intermediates
- Delamanid intermediates
- Brigatinib intermediates
- Palbociclib intermediates
- Lapatinib intermediates
- Sunitinib intermediates
- Ezetimibe intermediates
- Macitentan intermediates
- Idelalisib(CAL-101) API and
- Other